Doctor’s Data, Inc., in partnership with Kashi Clinical Laboratories, is pleased to announce the immediate availability of PCR testing of samples for SARS-COV-2 (COVID-19.) We will accept saliva samples or nasopharyngeal (NP) swab samples for testing. More information on sample collection criteria can be found here.
$100 for testing. Testing fees can be paid with test submission by the patient, billed to Medicare, private insurance, or the physician’s account. Saliva collection kits sold separately. Sign into your Doctor's Data account, then click here to purchase.
Specimens must be packaged, shipped, and transported according to the current edition of the International Air Transport Association (IATA) Dangerous Goods Regulation. Follow shipping regulations for UN 3373 Biological Substance, Category B when sending potential SARS-CoV-2 specimens. Alternatively, specimen transportation guidelines from CDC for SARS-CoV-2 specimens can be followed. (https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html)
This test has not been FDA cleared or approved. This LDT test has been authorized by FDA under an Emergency Use Authorization (EUA). This test has been validated in accordance with the FDA's Guidance Document (Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency) issued on February 29th, 2020. FDA independent review of this validation is pending. Samples should be collected in a healthcare setting with a practitioner present to supervise collection.
Please visit this page for other important updates specific to COVID-19 and your Doctor’s Data account.